Cargando…
Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth
Obesity is a significant risk factor for pancreatic cancer, harboring a chronic inflammatory condition characterized by dysregulation of the adipokines, leptin and adiponectin, that in turn alter oncogenic signaling pathways. We and others have shown that leptin promotes the proliferation and an inv...
Autores principales: | Messaggio, Fanuel, Mendonsa, Alisha M., Castellanos, Jason, Nagathihalli, Nagaraj S., Gorden, Lee, Merchant, Nipun B., VanSaun, Michael N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689616/ https://www.ncbi.nlm.nih.gov/pubmed/29156726 http://dx.doi.org/10.18632/oncotarget.19905 |
Ejemplares similares
-
Modulation of the Leptin Receptor Mediates Tumor Growth and Migration of Pancreatic Cancer Cells
por: Mendonsa, Alisha M., et al.
Publicado: (2015) -
Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells
por: Nagathihalli, Nagaraj S., et al.
Publicado: (2016) -
Hepatocellular Proliferation Correlates with Inflammatory Cell and Cytokine Changes in a Murine Model of Nonalchoholic Fatty Liver Disease
por: VanSaun, Michael N., et al.
Publicado: (2013) -
Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells
por: Manley, Sharon J., et al.
Publicado: (2022) -
Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells
por: Dosch, Austin R., et al.
Publicado: (2019)